Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Petros Pharmaceuticals Current Ratio 2013-2025 | PTPI

Petros Pharmaceuticals current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Petros Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.01B $0.03B 0.53
2024-12-31 $0.01B $0.02B 0.41
2024-09-30 $0.01B $0.01B 0.85
2024-06-30 $0.01B $0.01B 1.40
2024-03-31 $0.02B $0.01B 1.60
2023-12-31 $0.02B $0.01B 1.89
2023-09-30 $0.02B $0.01B 3.02
2023-06-30 $0.01B $0.01B 1.65
2023-03-31 $0.01B $0.01B 2.02
2022-12-31 $0.02B $0.01B 2.08
2022-09-30 $0.02B $0.01B 2.36
2022-06-30 $0.02B $0.01B 3.10
2022-03-31 $0.03B $0.01B 2.61
2021-12-31 $0.03B $0.03B 0.99
2021-09-30 $0.01B $0.03B 0.40
2021-06-30 $0.02B $0.03B 0.47
2021-03-31 $0.02B $0.04B 0.60
2020-12-31 $0.03B $0.04B 0.62
2020-09-30 $0.03B $0.00B 22.40
2020-06-30 $0.03B $0.00B 28.89
2020-03-31 $0.03B $0.00B 93.52
2019-12-31 $0.01B $0.04B 0.29
2019-09-30 $0.02B $0.00B 25.35
2019-06-30 $0.02B $0.00B 25.87
2019-03-31 $0.02B $0.00B 23.11
2018-12-31 $0.03B $0.00B 9.96
2018-09-30 $0.01B $0.00B 6.41
2018-06-30 $0.01B $0.00B 11.89
2018-03-31 $0.02B $0.00B 12.55
2017-12-31 $0.02B $0.00B 10.54
2017-09-30 $0.02B $0.00B 11.44
2017-06-30 $0.02B $0.00B 9.91
2017-03-31 $0.02B $0.00B 12.28
2016-12-31 $0.03B $0.00B 10.97
2016-09-30 $0.01B $0.00B 3.45
2016-06-30 $0.01B $0.00B 7.37
2016-03-31 $0.01B $0.00B 12.16
2015-12-31 $0.01B $0.00B 12.84
2015-09-30 $0.00B $0.00B 1.18
2015-06-30 $0.00B $0.00B 2.43
2015-03-31 $0.01B $0.00B 5.43
2014-12-31 $0.01B $0.00B 6.29
2014-09-30 $0.01B $0.00B 7.98
2014-06-30 $0.01B $0.00B 22.40
2014-03-31 $0.01B $0.00B 49.24
2013-12-31 $0.02B $0.00B 37.46
2013-09-30 $0.02B $0.00B 118.37
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.001B $0.005B
Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.235B 30.10
Zoetis (ZTS) United States $68.317B 25.49
Daiichi Sankyo, - (DSNKY) Japan $47.094B 24.14
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
BeOne Medicines - (ONC) Cayman Islands $32.313B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.352B 0.00
Summit Therapeutics (SMMT) United States $20.802B 0.00
Merck (MKKGY) Germany $17.312B 12.69
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.785B 12.19
Neurocrine Biosciences (NBIX) United States $13.228B 45.31
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $10.869B 0.00
Stevanato Group S.p.A (STVN) Italy $7.695B 47.06
Corcept Therapeutics (CORT) United States $7.252B 58.96
Madrigal Pharmaceuticals (MDGL) United States $6.811B 0.00
Grifols, S.A (GRFS) Spain $6.772B 0.00
Ionis Pharmaceuticals (IONS) United States $6.745B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.947B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.407B 0.00
Hypermarcas (HYPMY) Brazil $3.066B 20.17
Crinetics Pharmaceuticals (CRNX) United States $2.901B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.692B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.631B 9.22
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.529B 13.68
Centessa Pharmaceuticals (CNTA) United Kingdom $2.079B 0.00
Ocular Therapeutix (OCUL) United States $1.905B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.768B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.357B 0.00
Harrow (HROW) United States $1.356B 0.00
Guardian Pharmacy Services (GRDN) United States $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.242B 24.84
Enliven Therapeutics (ELVN) United States $1.097B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.071B 0.00
Dyne Therapeutics (DYN) United States $1.066B 0.00
Akebia Therapeutics (AKBA) United States $1.053B 0.00
Ardelyx (ARDX) United States $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $1.041B 5.62
Verve Therapeutics (VERV) United States $0.989B 0.00
ProKidney (PROK) United States $0.942B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.748B 0.00
Xencor (XNCR) United States $0.681B 0.00
USANA Health Sciences (USNA) United States $0.660B 13.27
Relay Therapeutics (RLAY) United States $0.650B 0.00
Zevra Therapeutics (ZVRA) United States $0.644B 0.00
Organogenesis (ORGO) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
Theravance Biopharma (TBPH) United States $0.565B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.531B 13.48
Siga Technologies (SIGA) United States $0.512B 10.69
Tourmaline Bio (TRML) United States $0.486B 0.00
Savara (SVRA) United States $0.430B 0.00
Aquestive Therapeutics (AQST) United States $0.423B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 10.18
Altimmune (ALT) United States $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.331B 0.00
AleAnna (ANNA) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
Heron Therapeutics (HRTX) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.273B 0.00
Esperion Therapeutics (ESPR) United States $0.264B 0.00
OmniAb (OABI) United States $0.263B 0.00
Larimar Therapeutics (LRMR) United States $0.241B 0.00
MediWound (MDWD) Israel $0.227B 0.00
4D Molecular Therapeutics (FDMT) United States $0.218B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Journey Medical (DERM) United States $0.172B 0.00
Liminatus Pharma (LIMN) United States $0.168B 0.00
Avita Medical (RCEL) United States $0.165B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Korro Bio (KRRO) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.147B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Cassava Sciences (SAVA) United States $0.130B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Champions Oncology (CSBR) United States $0.107B 24.22
Nutriband (NTRB) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Wellgistics Health (WGRX) United States $0.076B 0.00
Rafael Holdings (RFL) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 39.56
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Plus Therapeutics (PSTV) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.44
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.91
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00